Literature DB >> 34924891

Minimal Monitoring of Treatment for Hepatitis C Virus Infection.

Mark S Sulkowski1.   

Abstract

Entities:  

Year:  2021        PMID： 34924891      PMCID： PMC8667377     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.

Authors:  Elana S Rosenthal; Rachel Silk; Poonam Mathur; Chloe Gross; Rahwa Eyasu; Laura Nussdorf; Kristi Hill; Christopher Brokus; Aaron D'Amore; Nadeera Sidique; Phyllis Bijole; Miriam Jones; Randy Kier; Dana McCullough; David Sternberg; Kristen Stafford; Junfeng Sun; Henry Masur; Shyamasundaran Kottilil; Sarah Kattakuzhy
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

2.  Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.

Authors:  Marc G Ghany; Timothy R Morgan
Journal:  Hepatology       Date:  2020-02       Impact factor: 17.425

3.  Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial.

Authors:  Gregory J Dore; Jordan J Feld; Alex Thompson; Marianne Martinello; Andrew J Muir; Kosh Agarwal; Beat Müllhaupt; Heiner Wedemeyer; Karine Lacombe; Gail V Matthews; Michael Schultz; Marina Klein; Christophe Hezode; Gerard Estivill Mercade; Danny Kho; Kathy Petoumenos; Philippa Marks; Fernando Tatsch; Ana Gabriela Pires Dos Santos; Ed Gane
Journal:  J Hepatol       Date:  2019-10-23       Impact factor: 25.083

4.  Minimal Compared With Standard Monitoring During Sofosbuvir-Based Hepatitis C Treatment: A Randomized Controlled Trial.

Authors:  J S Davis; M Young; C Marshall; J Tate-Baker; M Madison; S Sharma; C Silva; T Jones; J Davies
Journal:  Open Forum Infect Dis       Date:  2020-01-19       Impact factor: 3.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.